drugset / Trial / NCT01110083
First-in-Man, Dose-escalation Trial of c-Met Kinase Inhibitor EMD 1204831 in Subjects With Advanced Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
EMD Serono has closed enrollment into this trial prior to determination of maximum tolerated dose (MTD). EMD Serono has decided not to pursue the development of EMD 1204831 in patients with advanced solid tumors for reasons other than safety.
Timeline
- Start
- 2010-04
- Primary completion
- 2012-03
- Completion
- —
Outcome
Outcome not reported
Stopped: “Please see "Purpose" statement below.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EMD 1204831 | Small molecule | — | — |